tistou and charlotte board of directors kerstan...
TRANSCRIPT
Blind Retinitis pigmentosa patient reading with a 1500 pixel chip
implanted under his retina
Supporting the Foundation
The KERSTAN FOUNDATION gratefully accepts donations in form of cash, checks and credit card transfers or in form
of pieces of art and of bequests.
Bank Account with Landesbank Baden-Wuerttemberg, Stuttgart
IBAN: DE54 6005 0101 0001 0300 00
BIC/SWIFT: SOLADEST
Non-profit status registered with
Regierungspraesidium Tuebingen Nr. 15-1/0563-49 Tue
UID Nr. DE814911621
Contact Information
Jasminweg 23, 72076 Tuebingen, Germany
Phone: +49 7071 650 512 Fax: +49 7071 650 515
Email: [email protected]
www.kerstanstiftung.org
Foundation Leadership
BOARD OF DIRECTORS
Egon Wolfgang Tistou Kerstan Prof. Dr. med. Dr. h. c. Eberhart Zrenner, Centre for Ophthalmology, University of Tuebingen, Germany Thomas Krause, Landesbank Baden-Wuerttemberg
MEMBER OF ADVISORY BOARD, PUBLIC RELATIONS
Dr. phil. Claudia Zrenner Prof. Dr. Hugo Hämmerle
Dr. Alfred Stett
SEAT OF FOUNDATION
Jasminweg 23, 72076 Tuebingen, Germany
Partnerships
Centre for Ophthalmology, University of Tuebingen, Germany Institute for Ophthalmic Research, University of Tuebingen, Germany
University Eye Hospital, University of Tuebingen
Ear-Nose-Throat Department University of Tuebingen, Cochlear Implant Centre
Centre for Neurosensory Systems (ZfN), University of Tuebingen
European Vision Institute (EVI), Brussels, Belgium Institut de la Vision, Paris, France
University of Oxford, England Moorfield’s Eye Hospital, London, England
Max-Planck-Institutes, Tuebingen AIBILI, Coimbra, Portugal
University of Lund, Dept. of Ophthalmology, Sweden Helmholtz Society, Munich
NMI Reutlingen Oregon Health and Science University, USA
NUS Eye Hospital, Singapore
Tistou and Charlotte Kerstan Foundation
Vision 2000
Established 1993 Purpose: To promote vision research at the University
of Tuebingen Centre for Ophthalmology in an interdis-ciplinary approach together with partners worldwide.
Mission
Develop solutions for incurable retinal diseases
Electronic chip with 1500 pixels implanted under a patient’s retina
Vision for the Future Centre for Ophthalmic Research where the blind and the visually impaired find a reliable diagnosis and effective treatment.
Recent Projects and Work in Progress
Year Project Amount €
2008-2012 Supporting new neuropharmaco-logical therapeutic approaches. Further development at the Low Vision Centre of the University of the University Eye Hospital, Tuebingen.
350.000
2010-2019 Founding an endowed professor-ship for molecular Mechanismus of hereditary retinal diseases at the Institute for Ophthalmic Research, Tübingen.
4.2 Million
2012 onwards
Development of new therapies for retinal degenerative diseases including gene therapy. Development of new diagnostic tools for early detection of retinal diseases; establishing links to the network for Rare Diseases.
Allocation of Funding What has the Foundation done in the Past?
Period Activity
1993-1999 It established the Low Vision Center in Tübingen,
funded research on neuroprotection,
supported young doctors studying genetics and hereditary diseases.
2000-2008 It supported a special clinic for vision disorders of unclear origin,
funded research on maintaining optic nerve function,
supported Orthoptics at the Low Vision Center, as well as RP clinics ,
provided initial funding for the subretinal chip project,
supported the elaboration of a Masterplan for Neuroprotective Therapies.
Funded a Senior Researcher in Residence, experimental therapies, animal models and a digitized patient database for clinical re-search purposes. For a list of publications, see www.eye.uni-tuebingen.de/zrenner/publications
Dr. med. Charlotte Kerstan (1924-2005) dedi-cated her entire professional life as an ophthalmologist to developing means of self- help, integration and rehabilitation for the visually disabled and blind. Together with her husband, a passionate landscape-architect, she created in 1993 the Tistou and Charlotte Kerstan Foundation – Vision 2000 that began its charitable work by funding a special clinic for the visually handicapped, the Low Vision Clinic in Tuebingen, or Sehbehindertenambulanz (SBA). Many of the retinal diseases, especially age-related macular degeneration (AMD) and hereditary forms are still incurable and affect over 1 million people in Germany alone. The Kerstan Foundation supports the search for new pharmacological, gene therapy and cell-based cures as well as the development of a subretinal chip in order to give the blind and visually disabled the perspective of a better quality of life in the future.
Recent Activities and Future Projects